Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Traws Pharma, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 18 | 22 | +4 |
| Shares | 1.30M | 3.42M | +2.11M (+162.0%) |
| Value | $2.41M | $3.86M | +$1.45M (+60.1%) |
New holders (9)
Institutions that held Traws Pharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squadron Capital Management LLC | 713,540 | $806.3K | 0.36% |
| Boothbay Fund Management, LLC | 194,536 | $219.8K | 0.01% |
| ADAR1 Capital Management, LLC | 154,431 | $174.5K | 0.01% |
| Seven Fleet Capital Management LP | 49,260 | $55.7K | 0.04% |
| State Street Corp | 25,802 | $29.2K | 0.00% |
| Citadel Advisors LLC | 24,819 | $28.0K | 0.00% |
| Susquehanna International Group, LLP | 14,197 | $16.0K | 0.00% |
| Advisor Group Holdings, Inc. | 8 | $9 | 0.00% |
| Robinswood Financial LLC | 5 | $5 | 0.00% |
Sold out (5)
Institutions that held Traws Pharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Vestal Point Capital, LP | 150,000 | $277.5K |
| HRT Financial LP | 12,573 | $23.0K |
| Morgan Stanley | 719 | $1.33K |
| Vermillion & White Wealth Management Group, LLC | 96 | $178 |
| Assetmark, Inc | 2 | $4 |